Table of Content
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Infections Diseases
4.2.2 Increasing Awareness about the Infections Among People
4.3 Market Restraints
4.3.1 Stringent Regulatory Norms by Government
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Immunoassays
5.1.2 Point of Care (POC)
5.1.3 Molecular diagnostics
5.1.4 Others
5.2 By End-user
5.2.1 Hospitals and clinics
5.2.2 Diagnostic laboratories
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific
6.1.2 Bio-Rad Laboratories
6.1.3 Quest Diagnostics Incorporate
6.1.4 Meridian Bioscience
6.1.5 F. Hoffmann-La Roche
6.1.6 Biohit Oyj
6.1.7 CorisBioConcept SPRL
6.1.8 CerTest BIOTEC
6.1.9 Epitope Diagnostics, Inc
6.1.10 Exalenz Bioscience Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS